Precision Optics (POCI) Q1 2027 earnings review
Precision Optics sales rise 22%, but its outlook stays flat
Precision Optics, a maker of miniature lenses and cameras for surgery and space satellites, held up better than feared as its largest customer ordered early. First-quarter sales rose 22% from a year ago to $8.2 million, and gross margin reached 22.5% without last quarter's one-time tariff refund. Chief executive Joe Forkey kept the full-year outlook unchanged, which by our math leaves revenue falling 6% over the rest of the year.
| Revenue | $8.2M +22% from a year ago |
|---|---|
| Gross margin | 22.5% 14.2% a year ago |
| Adjusted EBITDA (excluding one-offs) | -$0.2M -$1.2M a year ago |
| Full-year revenue outlook | Unchanged $30M–$33M (-0.1% at middle of range) |
⚖️ Verdict: ⚪ Neutral
The story is unchanged because management kept its full-year loss and revenue plan in place despite a good first quarter. Receiving a $2 million follow-on satellite order earlier than expected eases the fear that its top customer would halt orders for most of the year, and factory margins held above 22%. One caution: keeping the full-year plan after a small $0.2 million first-quarter Adjusted EBITDA loss means the company still plans for about $1.2 million of losses over the rest of the year, by our math.
The question now is whether the unchanged full-year plan is just cautious or if satellite and medical shipments will drop sharply in the second quarter. Either the early $2 million satellite order lifts second-half revenue above the plan, or a deeper second-quarter pause eats up the first quarter's progress. Next quarter's satellite revenue and any update to the full-year outlook will settle it.
🐂 Bull Case
Top Satellite Customer Placed a $2 Million Order Early
Precision Optics makes optical components that let satellites send data using lasers. Last quarter, chief executive Joe Forkey warned that its main aerospace customer would cut revenue by 40% in the first quarter to clear extra inventory. Instead, the program brought in $2.3 million, and after the quarter ended the customer placed a $2 million production order "earlier than we anticipated", Forkey said.
This early order matters because that single customer generated about 40% of total sales at its peak last year. A faster return to ordering reduces the risk of a long revenue gap this year, but the company still kept its full-year sales outlook flat.
What to watch: second-quarter satellite revenue when the company reports next quarter. Management previously expected sales to this customer to dip again in the second quarter before recovering later in the year.
Factory Efficiency Kept Gross Margin Above 22%
"Higher volumes and more efficient manufacturing helped lift gross margin and improved our Adjusted EBITDA," chief executive Joe Forkey said. Gross margin — the share of sales left after the cost of making the products — rose to 22.5% from 14.2% a year ago, as manufacturing costs fell by 8.4 percentage points of revenue.
The fourth quarter's 25.3% gross margin included a one-time tariff refund worth about 3 percentage points, so by our math the underlying margin was 22.3%. Holding 22.5% in the first quarter on lower total sales shows the factory yield improvements on medical scopes and optical assemblies are sticking without one-off credits.
What to watch: second-quarter gross margin. Holding above 20% if satellite shipments dip in the second quarter would show the factory can stay efficient even when its highest-margin line slows.
Medical and Defense Production Stepped Up
Precision Optics relies on medical devices and defense hardware to fill the gap while its main satellite customer adjusts inventory. Total production revenue grew 23% from a year ago to $7.4 million, supported by recent commercial hires and steady factory output across three programs.
- Single-use cystoscope (a disposable bladder camera): $1.8 million in first-quarter production revenue
- Single-use ophthalmic product (an eye-surgery device): $581,000 in revenue "as shipments increased under its $3.5 million follow-on order"
- Defense optics: a $1.3 million follow-on production order began shipping in October 2026
What to watch: quarterly revenue from the eye-surgery program across the rest of the year. Rising shipments there will show whether medical production can offset any second-quarter pause in satellite work.
🐻 Bear Case
Unchanged Plan Points to Deeper Losses Ahead
Chief executive Joe Forkey highlighted that first-quarter operating losses narrowed and the satellite customer ordered early. Yet the company left its full-year outlook unchanged, calling for $30 million to $33 million in revenue and an Adjusted EBITDA loss — cash operating profit before interest, taxes, depreciation and stock pay — of $1.2 million to $1.7 million.
First-quarter Adjusted EBITDA was a loss of $224,000 on $8.2 million of sales. By our math, the middle of the full-year plan leaves $23.3 million of revenue — down 6.1% from a year ago — and $1.23 million of Adjusted EBITDA losses across the rest of the year. Either the outlook is very cautious, or management still expects a steep drop in high-margin satellite shipments in the second quarter.
What to watch: any revision to the full-year loss outlook next quarter. Leaving the loss target unchanged again after the $2 million satellite order would confirm that costs or product mix are worsening.
Second Satellite Customer and Pipeline Remain Small
Precision Optics wants to turn its engineering design work into volume manufacturing, especially in space lasers. Chief executive Joe Forkey noted a "follow-on engineering order from a second U.S. space technology customer to support the design of its new satellite constellation". However, total engineering revenue was $728,000, up 11% from a year ago but down from $1.1 million two quarters ago.
The second space customer is still buying design services rather than factory production. In addition, the release gave no update on the joint surgery, digestive or robotic scopes that management previously said would enter production this year, so the business still depends heavily on its two existing programs.
What to watch: an initial production contract from the second satellite customer by the third quarter. Without a move from design to manufacturing, the new space customer will not contribute meaningful revenue this year.
Operating Cash Burn Returned and Share Count Rose 42%
Even with smaller accounting losses, the company burned $672,000 of cash in operations this quarter as it paid down $962,000 in supplier bills, compared with $78,000 of cash generated a year ago. Cash fell by $874,000 from June to $9.0 million, while two programs — satellite lasers and the bladder camera — still made up 50.3% of total revenue by our math.
Following the March 2026 stock sale, average shares rose 42.3% from a year ago to 11.0 million, and the company must keep at least $2.0 million in cash under its bank debt rules after three straight years of debt-coverage waivers. The $9.0 million cash balance gives a buffer today, but continued cash burn would shrink that cushion.
What to watch: operating cash flow and cash balances next quarter. A second quarter of nearly $900,000 in cash burn would eat into the March stock offering proceeds while the company waits for second-half orders.
💲 Other KPIs
Customer advances — cash deposits paid upfront for medical, defense and engineering work before shipment — dipped 6.2% from $2.50 million in June as the company shipped against its $3.5 million eye-surgery order. Even after the dip, the balance sits above the $1.82 million level from June 2025.
Overhead and sales costs fell 8.1% from $2.23 million a year ago, helped by lower stock-based pay. As a share of revenue, these expenses dropped by 8.2 percentage points by our math, from 33.4% to 25.1%, helping narrow the operating loss.
🔮 Guidance
Unchanged. The plan still calls for full-year sales of $31.5 million at the middle of the range, matching fiscal 2026's $31.5 million. After $8.2 million in the first quarter, by our math the plan leaves $23.3 million for the rest of the year, a 6.1% drop from the same three quarters last year.
Unchanged. The forecast still projects a full-year cash operating loss of $1.45 million at the middle of the range, or -4.6% of sales by our math. After a $224,000 loss in the first quarter, the outlook leaves $1.23 million in losses across the rest of the year (-5.3% of sales), reflecting management's history of cautious volume assumptions.
❓ Key Questions
Why keep the full-year outlook flat after the early satellite order?
First-quarter sales reached $8.2 million and the main satellite customer placed a $2 million order earlier than expected. Leaving the $30 million to $33 million target unchanged implies revenue will drop 6% over the rest of the year.
When will the $2 million satellite order ship?
Management previously said satellite orders take two to four months to turn into revenue because of supply-chain lead times. Knowing whether this order ships in the second or third quarter will clarify how deep the second-quarter dip will be.
What is the status of the three delayed medical scope programs?
Two quarters ago, the company said three programs — for joint, digestive and robotic surgery — would enter production within six months. None were mentioned in this release, and engineering revenue fell from recent peaks.
How is the bladder-camera customer's in-house factory line affecting orders?
The single-use cystoscope generated $1.8 million this quarter, down from its $2.2 million record two quarters ago. Investors need to know when the customer's own production line starts up and what royalty Precision Optics will earn.
